FDA advisory panel meetings: 60% had 1 or more undisclosed connections to big Pharma
Many patient, consumer reps on FDA advisory panels have ties to groups funded by pharma, analysis finds - Oct 2026
Nearly 40% of Food and Drug Administration advisory committee meetings held over a recent 20-year period included either a patient or consumer representative with active ties to an advocacy group funded by pharmaceutical companies, according to a new analysis. And for several committees, the number of such reps exceeded 50%.
In addition, more than one in 10 advisory committee meetings included a rep who was affiliated with an organization that received funding from the drugmaker whose medicine was being reviewed by the committees. Yet most of these organizational ties were not disclosed at the meetings, raising questions about voting behavior.
Related in VitaminDWiki
- New FDA head chosen because he had the fewest ties to big Pharma
- The US is not as healthy now, and the FDA is one of the reasons
- FDA - many studies
- FDA drug section gets 75% of its income from Big Pharma
- Off topic: Conflicts of Interest at the FDA - NYT
- Off Topic: FDA advisors have many conflicts of interest
Big Pharma in VitaminDWiki
- Big Pharma penalties in dollars: Pfizer 10 billion, J-J 24 billion, Merck 10 billion, GSK 9 billion
- Why Big Pharma is ‘TERRIFIED’ of Vitamin D - Dr. Korry
- Off Topic: Pharma Funded 2,400 State Lawmakers' Campaigns in 2020
- Extremely Big Pharma - many studies
- Big pharma is making money on drugs to treat vitamin D deficiency